BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 35879396)

  • 1. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines.
    Nummela P; Zafar S; Veikkolainen E; Ukkola I; Cinella V; Ayo A; Asghar MY; Välimäki N; Törnquist K; Karhu A; Laakkonen P; Aaltonen LA; Ristimäki A
    Int J Cancer; 2024 Jun; 154(11):1987-1998. PubMed ID: 38319157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic GNAS uses PKA-dependent and independent mechanisms to induce cell proliferation in human pancreatic ductal and acinar organoids.
    Desai R; Muthuswamy S
    bioRxiv; 2023 Jan; ():. PubMed ID: 36789419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginines of the CGN codon family are Achilles' heels of cancer genes.
    Trexler M; Bányai L; Kerekes K; Patthy L
    Sci Rep; 2024 May; 14(1):11715. PubMed ID: 38778164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroids-producing nodules: a two-layered adrenocortical nodular structure as a precursor lesion of cortisol-producing adenoma.
    Fukumoto T; Umakoshi H; Iwahashi N; Ogasawara T; Yokomoto-Umakoshi M; Kaneko H; Fujita M; Uchida N; Nakao H; Kawamura N; Matsuda Y; Sakamoto R; Miyazawa T; Seki M; Eto M; Oda Y; Suzuki Y; Ogawa S; Ogawa Y
    EBioMedicine; 2024 May; 103():105087. PubMed ID: 38570222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characterization of intramuscular myxomas.
    Hatchett WJ; Brunetti M; Andersen K; Tandsæther MR; Lobmaier I; Lund-Iversen M; Lien-Dahl T; Micci F; Panagopoulos I
    Pathol Oncol Res; 2024; 30():1611553. PubMed ID: 38317844
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma.
    Ito I; Yousef AMG; Chowdhury S; Dickson PN; Naini ZA; White MG; Fleten KG; Flatmark K; Fournier KF; Fowlkes NW; Shen JP
    Cancer Res; 2023 Oct; 83(19):3184-3191. PubMed ID: 37433032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial.
    Shen JP; Yousef AM; Zeineddine FA; Zeineddine MA; Tidwell RS; Beaty KA; Scofield LC; Rafeeq S; Hornstein N; Lano E; Eng C; Matamoros A; Foo WC; Uppal A; Scally C; Mansfield P; Taggart M; Raghav KP; Overman MJ; Fournier K
    JAMA Netw Open; 2023 Jun; 6(6):e2316161. PubMed ID: 37261831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GNAS Gene Mutation's Independent Expression in the Growth of Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Afolabi HA; Salleh SM; Zakaria Z; Ch'ng ES; Mohd Nafi SN; Abdul Aziz AAB; Irekeola AA; Wada Y; Al-Mhanna SB
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
    Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
    Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
    Lin YL; Ma R; Li Y
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological dysfunctions associated with mutations of the imprinted Gnas locus.
    Krechowec S; Plagge A
    Physiology (Bethesda); 2008 Aug; 23():221-9. PubMed ID: 18697996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene addiction to GNAS in GNAS
    More A; Ito I; Haridas V; Chowdhury S; Gu Y; Dickson P; Fowlkes N; Shen JP
    Oncogene; 2022 Aug; 41(35):4159-4168. PubMed ID: 35879396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced
    Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.
    Wilson CH; McIntyre RE; Arends MJ; Adams DJ
    Oncogene; 2010 Aug; 29(32):4567-75. PubMed ID: 20531296
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.